By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said Thursday after the close of the market that it expects to report total revenue for the fourth quarter of more than $355 million.

The updated preliminary results follow its Jan. 13 announcement, when the company had said that revenues for the quarter would be greater than $340 million. GAAP operating margin for Bruker Scientfic Instruments is now projected to exceed 18 percent, the company added. However, it did not provide a revenue figure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.